ARKG 03/08/2024

ARK publishes a holdings file for each trading day that records how many shares each fund owns. The Shares Held column draws from these files: it displays today’s share count, and the number in parentheses shows the difference obtained by comparing today’s file with the previous trading day’s file.

#DateCompanyTickerCUSIPWeightShares HeldMarket Value
103/08/2024CRISPR THERAPEUTICS AGCRSPH171821088.02%1,773,982 (0) (0%)$140,800,951.34
203/08/2024TWIST BIOSCIENCE CORPTWST90184D1006.01%2,776,088 (0) (0%)$105,463,583.12
303/08/2024RECURSION PHARMACEUTICALS-ARXRX75629V1045.54%8,720,195 (0) (0%)$97,230,174.25
403/08/2024EXACT SCIENCES CORPEXAS30063P1055.25%1,499,285 (0) (0%)$92,146,056.10
503/08/2024BEAM THERAPEUTICS INCBEAM07373V1054.63%2,198,027 (0) (0%)$81,239,077.92
603/08/2024CAREDX INCCDNA14167L1034.08%5,997,266 (0) (0%)$71,607,356.04
703/08/2024INTELLIA THERAPEUTICS INCNTLA45826J1054.00%2,340,122 (0) (0%)$70,250,462.44
803/08/2024SCHRODINGER INCSDGR80810D1033.93%2,575,222 (0) (0%)$69,015,949.60
903/08/2024GINKGO BIOWORKS HOLDINGS INCDNA37611X1003.70%54,157,571 (0) (0%)$64,989,085.20
1003/08/2024ARCTURUS THERAPEUTICS HOLDINARCT UQ03969T1093.66%1,728,244 (0) (0%)$64,273,394.36
1103/08/2024IONIS PHARMACEUTICALS INCIONS4622221003.64%1,431,127 (0) (0%)$63,928,443.09
1203/08/202410X GENOMICS INC-CLASS ATXG88025U1093.45%1,475,606 (0) (0%)$60,455,577.82
1303/08/2024ACCOLADE INCACCD00437E1023.12%5,738,438 (0) (0%)$54,687,314.14
1403/08/2024PACIFIC BIOSCIENCES OF CALIFPACB69404D1083.10%11,852,055 (0) (0%)$54,400,932.45
1503/08/2024TELADOC HEALTH INCTDOC87918A1052.90%3,311,602 (0) (0%)$50,833,090.70
1603/08/2024VERACYTE INCVCYT92337F1072.61%2,012,308 (0) (0%)$45,780,007.00
1703/08/2024VEEVA SYSTEMS INC-CLASS AVEEV9224751082.51%191,262 (0) (0%)$44,022,774.54
1803/08/2024VERVE THERAPEUTICS INCVERV92539P1012.47%2,899,441 (0) (0%)$43,317,648.54
1903/08/2024VERTEX PHARMACEUTICALS INCVRTX92532F1002.34%100,098 (0) (0%)$41,094,232.92
2003/08/2024NURIX THERAPEUTICS INCNRIX67080M1032.23%2,694,038 (0) (0%)$39,063,551.00
2103/08/2024ADAPTIVE BIOTECHNOLOGIESADPT00650F1092.12%10,806,196 (0) (0%)$37,281,376.20
2203/08/2024STANDARD BIOTOOLS INCLAB34385P1082.08%13,334,874 (0) (0%)$36,537,554.76
2303/08/2024MODERNA INCMRNA60770K1071.96%346,003 (0) (0%)$34,420,378.44
2403/08/2024908 DEVICES INCMASS65443P1021.56%3,943,841 (14,650) (0.37%)$27,370,256.54
2503/08/2024QUANTUM-SI INCQSI74765K1051.56%13,057,989 (0) (0%)$27,291,197.01
2603/08/2024INCYTE CORPINCY45337C1021.51%448,648 (0) (0%)$26,483,691.44
2703/08/2024UIPATH INC – CLASS APATH90364P1051.45%1,077,513 (-6,321) (-0.58%)$25,429,306.80
2803/08/2024PRIME MEDICINE INCPRME74168J1011.44%3,110,739 (0) (0%)$25,321,415.46
2903/08/2024COMPASS PATHWAYS PLCCMPS20451W1011.42%2,210,111 (0) (0%)$24,930,052.08
3003/08/2024REGENERON PHARMACEUTICALSREGN75886F1071.18%21,353 (0) (0%)$20,783,088.43
3103/08/2024ABSCI CORPABSI00091E1090.98%3,350,587 (0) (0%)$17,188,511.31
3203/08/2024REPARE THERAPEUTICS INCRPTX7602731020.95%2,765,562 (0) (0%)$16,593,372.00
3303/08/2024BUTTERFLY NETWORK INCBFLY1241551020.84%11,550,981 (0) (0%)$14,785,255.68
3403/08/2024AMGEN INCAMGN0311621000.82%52,811 (0) (0%)$14,410,009.46
3503/08/2024CERUS CORPCERS1570851010.80%5,899,543 (0) (0%)$14,040,912.34
3603/08/2024NVIDIA CORPNVDA67066G1040.62%11,788 (0) (0%)$10,923,821.72
3703/08/2024PERSONALIS INCPSNL71535D1060.54%5,604,523 (45,999) (0.83%)$9,415,598.64
3803/08/2024NATERA INCNTRA6323071040.44%84,663 (0) (0%)$7,760,210.58
3903/08/2024GUARDANT HEALTH INCGH40131M1090.42%369,276 (0) (0%)$7,333,821.36
4003/08/2024SENTI BIOSCIENCES INCSNTI81726A1000.04%1,651,780 (0) (0%)$664,841.45
4103/08/2024GOLDMAN FS TRSY OBLIG INST 468X9USDGSFT0.04%774,011 (-583,007) (-42.96%)$774,011.27
4203/08/2024Senti Bio – place holdersharesDNBLFB2Y20.01%243,471 (0) (0%)$97,997.08
4303/08/2024PFIZER INCPFE7170811030.01%6,453 (0) (0%)$172,875.87
Source: https://assets.ark-funds.com/fund-documents/funds-etf-csv/ARK_GENOMIC_REVOLUTION_ETF_ARKG_HOLDINGS.csv

Discover more from ARK Invest Daily Trades Tracker

Subscribe to get the latest posts sent to your email.

Leave a Comment